These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 18160837)
1. [Development of a web-based program for the identification of human leukocyte antigen antibody specificities]. Cha CH; Oh HB; Kim MH; Chae JM; Jung SY Korean J Lab Med; 2007 Dec; 27(6):458-63. PubMed ID: 18160837 [TBL] [Abstract][Full Text] [Related]
2. [Experience on identification of cross-reactive group specificity performed by anti-human globulin panel reactive antibody tests]. Sohn YH; Cha CH; Kim MH; Ko SY; Oh HB Korean J Lab Med; 2008 Oct; 28(5):362-70. PubMed ID: 18971617 [TBL] [Abstract][Full Text] [Related]
3. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463 [TBL] [Abstract][Full Text] [Related]
4. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant. Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396 [TBL] [Abstract][Full Text] [Related]
5. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants. Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806 [TBL] [Abstract][Full Text] [Related]
6. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Duquesnoy RJ; Marrari M Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979 [TBL] [Abstract][Full Text] [Related]
7. Anti-HLA antibody profile of Turkish patients with end-stage renal disease. Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361 [TBL] [Abstract][Full Text] [Related]
8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
9. Investigations into the lack of consensus in the reporting of HLA antibody specificities in the UK. Wortley A; Mckinley K; Whittle R; Calvert A; Shaw O; Fernando R; Pearse A; Hopkins K; Clark B J Clin Pathol; 2009 Mar; 62(3):270-4. PubMed ID: 19251955 [TBL] [Abstract][Full Text] [Related]
10. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Duquesnoy RJ; Howe J; Takemoto S Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520 [TBL] [Abstract][Full Text] [Related]
11. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Barocci S; Valente U; Nocera A Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591 [TBL] [Abstract][Full Text] [Related]